188 related articles for article (PubMed ID: 35163828)
1. The Expression of TP53-Induced Glycolysis and Apoptosis Regulator (TIGAR) Can Be Controlled by the Antioxidant Orchestrator NRF2 in Human Carcinoma Cells.
Simon-Molas H; Sánchez-de-Diego C; Navarro-Sabaté À; Castaño E; Ventura F; Bartrons R; Manzano A
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163828
[TBL] [Abstract][Full Text] [Related]
2. TIGAR alleviates oxidative stress in brain with extended ischemia via a pentose phosphate pathway-independent manner.
Liu M; Zhou X; Li Y; Ma S; Pan L; Zhang X; Zheng W; Wu Z; Wang K; Ahsan A; Wu J; Jiang L; Lu Y; Hu W; Qin Z; Chen Z; Zhang X
Redox Biol; 2022 Jul; 53():102323. PubMed ID: 35576689
[TBL] [Abstract][Full Text] [Related]
3. p53-TP53-Induced Glycolysis Regulator Mediated Glycolytic Suppression Attenuates DNA Damage and Genomic Instability in Fanconi Anemia Hematopoietic Stem Cells.
Li X; Wu L; Zopp M; Kopelov S; Du W
Stem Cells; 2019 Jul; 37(7):937-947. PubMed ID: 30977208
[TBL] [Abstract][Full Text] [Related]
4. Tp53-induced glycolysis and apoptosis regulator (TIGAR) protects glioma cells from starvation-induced cell death by up-regulating respiration and improving cellular redox homeostasis.
Wanka C; Steinbach JP; Rieger J
J Biol Chem; 2012 Sep; 287(40):33436-46. PubMed ID: 22887998
[TBL] [Abstract][Full Text] [Related]
5. TIGAR, a p53-inducible regulator of glycolysis and apoptosis.
Bensaad K; Tsuruta A; Selak MA; Vidal MN; Nakano K; Bartrons R; Gottlieb E; Vousden KH
Cell; 2006 Jul; 126(1):107-20. PubMed ID: 16839880
[TBL] [Abstract][Full Text] [Related]
6. TP53-inducible Glycolysis and Apoptosis Regulator (TIGAR) Metabolically Reprograms Carcinoma and Stromal Cells in Breast Cancer.
Ko YH; Domingo-Vidal M; Roche M; Lin Z; Whitaker-Menezes D; Seifert E; Capparelli C; Tuluc M; Birbe RC; Tassone P; Curry JM; Navarro-Sabaté À; Manzano A; Bartrons R; Caro J; Martinez-Outschoorn U
J Biol Chem; 2016 Dec; 291(51):26291-26303. PubMed ID: 27803158
[TBL] [Abstract][Full Text] [Related]
7. TCF19 and p53 regulate transcription of TIGAR and SCO2 in HCC for mitochondrial energy metabolism and stress adaptation.
Mondal P; Gadad SS; Adhikari S; Ramos EI; Sen S; Prasad P; Das C
FASEB J; 2021 Sep; 35(9):e21814. PubMed ID: 34369624
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of TIGAR Increases Exogenous p53 and Cisplatin Combination Sensitivity in Lung Cancer Cells by Regulating Glycolytic Flux.
Fu J; Yu S; Zhao X; Zhang C; Shen L; Liu Y; Yu H
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555672
[TBL] [Abstract][Full Text] [Related]
9. Ablation of cardiac TIGAR preserves myocardial energetics and cardiac function in the pressure overload heart failure model.
Okawa Y; Hoshino A; Ariyoshi M; Kaimoto S; Tateishi S; Ono K; Uchihashi M; Iwai-Kanai E; Matoba S
Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1366-H1377. PubMed ID: 30901275
[TBL] [Abstract][Full Text] [Related]
10. Acetylation mediated by the p300/CBP-associated factor determines cellular energy metabolic pathways in cancer.
Rajendran R; Garva R; Ashour H; Leung T; Stratford I; Krstic-Demonacos M; Demonacos C
Int J Oncol; 2013 Jun; 42(6):1961-72. PubMed ID: 23591450
[TBL] [Abstract][Full Text] [Related]
11. p53- and p73-independent activation of TIGAR expression in vivo.
Lee P; Hock AK; Vousden KH; Cheung EC
Cell Death Dis; 2015 Aug; 6(8):e1842. PubMed ID: 26247727
[TBL] [Abstract][Full Text] [Related]
12. The Effect of TIGAR Knockdown on Apoptotic and Epithelial-Mesenchymal Markers Expression in Doxorubicin-Resistant Non-Small Cell Lung Cancer A549 Cell Lines.
Agca CA; Kırıcı M; Nedzvetsky VS; Gundogdu R; Tykhomyrov AA
Chem Biodivers; 2020 Sep; 17(9):e2000441. PubMed ID: 32639659
[TBL] [Abstract][Full Text] [Related]
13. TP53-induced glycolysis and apoptosis regulator (TIGAR) ameliorates lysosomal damage in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-mediated mouse model of Parkinson's disease.
Ge J; Lin H; Yang J; Li Q; Zhou J; Qin Z; Wu F
Toxicol Lett; 2021 Mar; 339():60-69. PubMed ID: 33359019
[TBL] [Abstract][Full Text] [Related]
14. ATM-NFκB axis-driven TIGAR regulates sensitivity of glioma cells to radiomimetics in the presence of TNFα.
Sinha S; Ghildiyal R; Mehta VS; Sen E
Cell Death Dis; 2013 May; 4(5):e615. PubMed ID: 23640457
[TBL] [Abstract][Full Text] [Related]
15. p53 and TIGAR regulate cardiac myocyte energy homeostasis under hypoxic stress.
Kimata M; Matoba S; Iwai-Kanai E; Nakamura H; Hoshino A; Nakaoka M; Katamura M; Okawa Y; Mita Y; Okigaki M; Ikeda K; Tatsumi T; Matsubara H
Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1908-16. PubMed ID: 20935145
[TBL] [Abstract][Full Text] [Related]
16. The NRF2 transcriptional target NQO1 has low mRNA levels in TP53-mutated endometrial carcinomas.
Beinse G; Just PA; Rance B; Izac B; Letourneur F; Saidu NEB; Chouzenoux S; Nicco C; Goldwasser F; Pasmant E; Batteux F; Borghese B; Alexandre J; Leroy K
PLoS One; 2019; 14(3):e0214416. PubMed ID: 30908539
[TBL] [Abstract][Full Text] [Related]
17. Sirtuin 3 Alleviates Diabetic Cardiomyopathy by Regulating TIGAR and Cardiomyocyte Metabolism.
Li L; Zeng H; He X; Chen JX
J Am Heart Assoc; 2021 Feb; 10(5):e018913. PubMed ID: 33586458
[TBL] [Abstract][Full Text] [Related]
18. TP53-Induced Glycolysis and Apoptosis Regulator (TIGAR) Is Upregulated in Lymphocytes Stimulated with Concanavalin A.
Simon-Molas H; Vallvé-Martínez X; Caldera-Quevedo I; Fontova P; Arnedo-Pac C; Vidal-Alabró A; Castaño E; Navarro-Sabaté À; Lloberas N; Bartrons R; Manzano A
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299056
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic role of the TP53-induced glycolysis and apoptosis regulator in nasopharyngeal carcinoma through NF-κB pathway modulation.
Zhao M; Fan J; Liu Y; Yu Y; Xu J; Wen Q; Zhang J; Fu S; Wang B; Xiang L; Feng J; Wu J; Yang L
Int J Oncol; 2016 Feb; 48(2):756-64. PubMed ID: 26691054
[TBL] [Abstract][Full Text] [Related]
20. Metabolic remodeling by TIGAR overexpression is a therapeutic target in esophageal squamous-cell carcinoma.
Chu J; Niu X; Chang J; Shao M; Peng L; Xi Y; Lin A; Wang C; Cui Q; Luo Y; Fan W; Chen Y; Sun Y; Guo W; Tan W; Lin D; Wu C
Theranostics; 2020; 10(8):3488-3502. PubMed ID: 32206103
[No Abstract] [Full Text] [Related]
[Next] [New Search]
